Insiders · CODX

Ted Murphy

Director at Co-Diagnostics, Inc. (CODX)

Ted Murphy has filed 12 insider reports with the SEC since January 2022, as director at Co-Diagnostics, Inc. (CODX). The latest filing, on August 15, 2025, reports grant or award at Co-Diagnostics, Inc. (CODX).

Filings
12
Companies
1
Bought on market
None
Sold on market
None

Companies where Ted Murphy is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Co-Diagnostics, Inc. logo
CODX
Co-Diagnostics, Inc.
Director224,167$0.1295Aug 15, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Ted Murphy with

Other insiders at the same companies

Questions about Ted Murphy

What is Ted Murphy's role at Co-Diagnostics, Inc.?
Ted Murphy reports to the SEC as director at Co-Diagnostics, Inc. (CODX), according to the latest filing on August 15, 2025.
How many shares does Ted Murphy own?
After the latest filing that states it, Ted Murphy directly owned 224,167 shares of Co-Diagnostics, Inc. (CODX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Ted Murphy bought or sold stock recently?
No open-market purchases or sales by Ted Murphy are on file. The filings report grant or award and exercise or conversion of a derivative.
How do I get alerts when Ted Murphy files?
Follow Ted Murphy on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Ted Murphy (SEC CIK 0001685432). Totals count each trade once, skipping amendments whose original is on file, from Jan 10, 2022 on. View on SEC EDGAR · Get this as JSON